Monosodium Glutamate Reduces 68Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model

Autor: Kuo-Shyan Lin, Navjit Hundal-Jabal, Joseph Lau, Etienne Rousseau, Nadine Colpo, Helen Merkens, Hsiou-Ting Kuo, Zhengxing Zhang, Francois Benard
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Glutamate Carboxypeptidase II
Male
Monosodium glutamate
medicine.medical_treatment
salivary glands
Mice
SCID

Theranostic Nanomedicine
030218 nuclear medicine & medical imaging
68Ga-PSMA-11
Prostate cancer
chemistry.chemical_compound
prostate-specific membrane antigen
Mice
0302 clinical medicine
Mice
Inbred NOD

Positron Emission Tomography Computed Tomography
Sodium Glutamate
Tissue Distribution
Saline
Gallium Isotopes
Kidney
3. Good health
medicine.anatomical_structure
030220 oncology & carcinogenesis
Antigens
Surface

Oligopeptides
Biodistribution
medicine.medical_specialty
kidney
Biological Transport
Active

Gallium Radioisotopes
Radiation-Protective Agents
03 medical and health sciences
Internal medicine
Cell Line
Tumor

LNCaP
medicine
Animals
Humans
Radiology
Nuclear Medicine and imaging

Basic
Edetic Acid
Membrane antigen
business.industry
monosodium glutamate
Prostatic Neoplasms
medicine.disease
Theranostics
Endocrinology
chemistry
Radiopharmaceuticals
business
Zdroj: Journal of Nuclear Medicine
ISSN: 1535-5667
0161-5505
Popis: We evaluated the ability of monosodium glutamate (MSG) to reduce salivary and kidney uptake of a prostate-specific membrane antigen (PSMA) radioligand without affecting tumor uptake. Methods: LNCaP tumor–bearing mice were intraperitoneally injected with MSG (657, 329, or 164 mg/kg) or phosphate-buffered saline (PBS). Fifteen minutes later, the mice were intravenously administered 68Ga-PSMA-11. PET/CT imaging and biodistribution studies were performed 1 h after administration. Results: Tumor uptake (percentage injected dose per gram [%ID]) was not statistically different between groups, at 8.42 ± 1.40 %ID in the 657 mg/kg group, 7.19 ± 0.86 %ID in the 329 mg/kg group, 8.20 ± 2.44 %ID in the 164 mg/kg group, and 8.67 ± 1.97 %ID in the PBS group. Kidney uptake was significantly lower in the 657 mg/kg group (85.8 ± 24.2 %ID) than in the 329 mg/kg (159 ± 26.2 %ID), 164 mg/kg (211 ± 27.4 %ID), and PBS groups (182 ± 33.5 %ID) (P < 0.001). Salivary gland uptake was lower in the 657 mg/kg (3.72 ± 2.12 %ID) and 329 mg/kg (5.74 ± 0.62 %ID) groups than in the PBS group (10.04 ± 2.52 %ID) (P < 0.01). Conclusion: MSG decreased salivary and kidney uptake of 68Ga-PSMA-11 in a dose-dependent manner, whereas tumor uptake was unaffected.
Databáze: OpenAIRE